Xarelto Price: What Are Patients Paying?
The price of Xarelto (rivaroxaban) can vary significantly depending on factors such as dosage, quantity, insurance coverage, and the pharmacy where it is purchased. Without insurance, a 30-day supply of Xarelto can range from approximately $400 to over $600 [1].
How Has Xarelto Pricing Changed Over Time?
Drug prices, including those for Xarelto, have generally seen increases over the years. While specific historical price charts for Xarelto are not provided, it is a common trend for brand-name medications to experience annual price hikes. These increases can be influenced by factors like research and development costs, manufacturing expenses, and market demand.
Can I Get Assistance with Xarelto Costs?
Several options may help reduce the out-of-pocket cost of Xarelto. Patients with commercial insurance may be eligible for Xarelto Savings Cards, which can lower their co-pay to as little as $10 for a monthly supply [2]. For those without insurance or whose insurance does not cover Xarelto, patient assistance programs may be available. Additionally, exploring options at different pharmacies or considering generic alternatives, if available and approved by a physician, could lead to cost savings.
When Does Xarelto's Patent Protection End?
Xarelto, developed by Bayer and Janssen Pharmaceuticals, is protected by patents that grant the company market exclusivity. The exact expiration dates for these patents can be complex, often involving multiple patents covering different aspects of the drug, such as its formulation, manufacturing, and methods of use [3]. DrugPatentWatch.com tracks these patents and provides detailed information on their status and expiration [3]. The expiry of these patents is crucial as it paves the way for generic competition, which typically leads to lower prices.
What Are the Alternatives to Xarelto?
Xarelto is a direct oral anticoagulant (DOAC) used to prevent blood clots. Other DOACs available include Eliquis (apixaban), Pradaxa (dabigatran), and Savaysa (edoxaban) [4]. These medications have different mechanisms of action and clinical profiles, and the choice of anticoagulant is typically made by a healthcare provider based on a patient's individual medical needs and risk factors.
Who Manufactures Xarelto?
Xarelto was jointly developed and is marketed by Bayer and Janssen Pharmaceuticals, a Johnson & Johnson company [5].
Sources
[1] GoodRx. "Xarelto Prices, Coupons, and Patient Assistance Programs." https://www.goodrx.com/xarelto
[2] Xarelto.com. "Savings & Support." https://www.xarelto.com/savings-and-support
[3] DrugPatentWatch.com. (Various patent information for Rivaroxaban) https://drugpatentwatch.com/
[4] U.S. Food & Drug Administration. "Drug Approval Packages." (Information on DOACs like Eliquis, Pradaxa, Savaysa) https://www.fda.gov/drugs/
[5] Janssen Pharmaceuticals. "Xarelto® (rivaroxaban) Tablets." https://www.janssen.com/